Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An Updated Evaluation of Atrazine-Cancer Incidence Associations among Pesticide Applicators in the Agricultural Health Study Cohort.
Remigio RV, Andreotti G, Sandler DP, Erickson PA, Koutros S, Albert PS, Hurwitz LM, Parks CG, Lubin JH, Hofmann JN, Beane Freeman LE. Remigio RV, et al. Among authors: lubin jh. Environ Health Perspect. 2024 Feb;132(2):27010. doi: 10.1289/EHP13684. Epub 2024 Feb 21. Environ Health Perspect. 2024. PMID: 38381478 Free PMC article.
Corrigendum to "Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus" [Heliyon 9(4) (April 2023) e15032].
Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Hernandez NE, et al. Among authors: lubin jh. Heliyon. 2023 Jul 6;9(8):e17901. doi: 10.1016/j.heliyon.2023.e17901. eCollection 2023 Aug. Heliyon. 2023. PMID: 37701412 Free PMC article.
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus.
Hernandez NE, Jankowski W, Frick R, Kelow SP, Lubin JH, Simhadri V, Adolf-Bryfogle J, Khare SD, Dunbrack RL Jr, Gray JJ, Sauna ZE. Hernandez NE, et al. Among authors: lubin jh. Heliyon. 2023 Apr;9(4):e15032. doi: 10.1016/j.heliyon.2023.e15032. Epub 2023 Apr 3. Heliyon. 2023. PMID: 37035348 Free PMC article.
A comprehensive survey of coronaviral main protease active site diversity in 3D: Identifying and analyzing drug discovery targets in search of broad specificity inhibitors for the next coronavirus pandemic.
Lubin JH, Martinusen SG, Zardecki C, Olivas C, Bacorn M, Balogun M, Slaton EW, Wu AW, Sakeer S, Hudson BP, Denard CA, Burley SK, Khare SD. Lubin JH, et al. bioRxiv [Preprint]. 2023 Jan 31:2023.01.30.526101. doi: 10.1101/2023.01.30.526101. bioRxiv. 2023. PMID: 36778399 Free PMC article. Preprint.
Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection.
Markosian C, Staquicini DI, Dogra P, Dodero-Rojas E, Lubin JH, Tang FHF, Smith TL, Contessoto VG, Libutti SK, Wang Z, Cristini V, Khare SD, Whitford PC, Burley SK, Onuchic JN, Pasqualini R, Arap W. Markosian C, et al. Among authors: lubin jh. Mol Biol Evol. 2022 May 3;39(5):msac091. doi: 10.1093/molbev/msac091. Mol Biol Evol. 2022. PMID: 35511693 Free PMC article.
262 results